Zobrazeno 1 - 8 of 8 pro vyhledávání: '"Huub Kreuwel"'
1
Akademický článek
IVIG response in pediatric acute-onset neuropsychiatric syndrome correlates with reduction in pro-inflammatory monocytes and neuropsychiatric measures
Autor: Isaac Melamed, Shamma Rahman, Heather Pein, Melinda Heffron, Jennifer Frankovich, Huub Kreuwel, Elizabeth D. Mellins
Publikováno v: Frontiers in Immunology, Vol 15 (2024)
IntroductionPediatric Acute-Onset Neuropsychiatric Syndrome (PANS) is characterized by abrupt onset of obsessive-compulsive disorder or eating restriction along with the abrupt onset of other co-occurring symptoms (tics, behavioral and cognitive regr
Externí odkaz: https://doaj.org/article/36255bf5d3eb430f9676cacfc81cb8f0
Zobrazit plný text záznamu
2
Subcutaneous immunoglobulin 16.5% for the treatment of pediatric patients with primary antibody immunodeficiency
Autor: Sudhir, Gupta, Roger H, Kobayashi, Jiří, Litzman, Laurel, Cherwin, Sonja, Hoeller, Huub, Kreuwel
Publikováno v: Expert Review of Clinical Immunology. 19:7-17
Human immunoglobulin (IG) administered intravenously (IVIG) or subcutaneously (SCIG) is used to prevent infections in patients with primary immunodeficiency diseases (PIDDs) such as primary antibody immunodeficiencies.This review provides an overview
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3564d3b9617ecd2b5b95c19390032de9
https://doi.org/10.1080/1744666x.2023.2144836
Zobrazit plný text záznamu
3
Long-term efficacy, safety, and tolerability of a subcutaneous immunoglobulin 16.5% (cutaquig®) in the treatment of patients with primary immunodeficiencies
Autor: Roger H, Kobayashi, Jiří, Litzman, Isaac, Melamed, J Fernando, Mandujano, Ai Lan, Kobayashi, Bruce, Ritchie, Bob, Geng, T Prescott, Atkinson, Syed, Rehman, Sonja, Höller, Eva, Turpel-Kantor, Huub, Kreuwel, J C, Speer, Sudhir, Gupta
Publikováno v: Clinical and Experimental Immunology. 210:91-103
A prospective study and its long-term extension examined whether weekly treatment of patients with primary immunodeficiencies (PIDs) with a 16.5% subcutaneous immunoglobulin (SCIg; cutaquig®) confers acceptable efficacy, safety, and tolerability ove
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b5ba846a028013e90b729c894cda558
https://doi.org/10.1093/cei/uxac092
Zobrazit plný text záznamu
4
Subcutaneous Immunoglobulin 16.5% (Cutaquig®) in Primary Immunodeficiency Disease: Safety, Tolerability, Efficacy, and Patient Experience with Enhanced Infusion Regimens
Autor: Sudhir Gupta, James DeAngelo, Isaac Melamed, Jolan E. Walter, Ai-Lan Kobayashi, Tracy Bridges, J. Wesley Sublett, Jonathan A. Bernstein, Alan Koterba, Michael Manning, Joanna Maltese, Sonja Hoeller, Eva Turpel-Kantor, Huub Kreuwel, Roger H. Kobayashi
Publikováno v: Journal of Clinical Immunology.
Purpose To achieve reductions in infusion time, infusion sites, and frequency, a prospective, open-label, multicenter, Phase 3 study evaluated the safety, efficacy, and tolerability of subcutaneous immunoglobulin (SCIG) 16.5% (Cutaquig®, Octapharma)
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e032fde4f9e7c9f51febd51147c3e6d1
https://doi.org/10.1007/s10875-023-01509-4
Zobrazit plný text záznamu
6
Overview of subcutaneous immunoglobulin 16.5% in primary and secondary immunodeficiency diseases
Autor: Roger H Kobayashi, Jiří Litzman, Syed Rizvi, Huub Kreuwel, Sonja Hoeller, Sudhir Gupta
Publikováno v: Immunotherapy. 14(4)
Most primary immunodeficiency diseases, and select secondary immunodeficiency diseases, are treated with immunoglobulin (IG) therapy, administered intravenously or subcutaneously (SCIG). The first instance of IG replacement for primary immunodeficien
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd89ce8dfdeb49d884cdd44c740089d1
https://pubmed.ncbi.nlm.nih.gov/34986666
Zobrazit plný text záznamu
8
Regulation of the flavin redox potential by flavin-binding antibodies
Autor: Y.E. Bruggeman, Arjen Schots, Huub Kreuwel, Annemarie Honegger, Colja Laane, Riet Hilhorst, Antonie J. W. G. Visser
Publikováno v: Scopus-Elsevier
European Journal of Biochemistry 249 (1997)
European Journal of Biochemistry, 249, 393-400
Single-chain Fv antibody fragments binding different flavin forms [10-(5'-carboxybutyl-)flavin (Fl[ox]) and 10-(5'-carboxybutyl)-1,5-dihydroflavin (Fl[red])] have been generated from an antibody phage-display library to study how a protein environmen
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57758c53b4da563a168f3750658a4223
https://pubmed.ncbi.nlm.nih.gov/9370345
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje